Close Menu

NEW YORK (GenomeWeb) – Genomics firm Centrillion Biosciences this month received a two-year Small Business Innovation Research grant from the National Institutes of Health to develop a DNA barcode array for the phased sequencing of whole genomes.

The award, the company stated in the grant's abstract, will be used to optimize the fabrication of DNA chips to reduce their feature size and pitch; reverse the orientation of oligonucleotide primers to make their 3' ends free for extension; and increase the length and accuracy of the oligosynthesis process.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.